Survey PAH-Tracleer Trends in Use_AUG2006
August 2006

Deliverable: Raw Data and PowerPoint Presentation

Primary Objective: To understand current perceptions and usage as well as the future potential of Tracleer (bosentan) in the treatment of PAH

Objectives:

• To assess current physician opinion and prescribing practices of Tracleer (bosentan) for PAH
• To evaluate current patient perceptions of Tracleer (bosentan)
• To estimate future use of Tracleer (bosentan) given availability of emerging agents for PAH

Products Highlighted:

• Tracleer (bosentan)
• Thelin(sitaxsentan)
• ambrisentan

Topics:

• Current Treatments for Pulmonary Arterial Hypertension (PAH)
• Potential Future Treatments for PAH

Screening Criteria:

• The sample consists of 41 Pulmonologists from across the US
• board-certified in pulmonology
• Have been in practice between 3 and 30 years
• Spend at least 75% of their professional time in clinical practice
• Manage at least 10 PAH patients per month
• Currently prescribe Tracleer